Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pDONR221_SLC6A3 Citations (2)

Originally described in: A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.
Sijben HJ, van den Berg JJE, Broekhuis JD, IJzerman AP, Heitman LH Sci Rep. 2021 Jan 14;11(1):1312. doi: 10.1038/s41598-020-79218-w. PubMed Journal

Articles Citing pDONR221_SLC6A3

Articles
A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery. Sijben HJ, van den Berg JJE, Broekhuis JD, IJzerman AP, Heitman LH. Sci Rep. 2021 Jan 14;11(1):1312. doi: 10.1038/s41598-020-79218-w. PubMed

Associated Plasmids
Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma. Yin X, Chen H, Chen S, Zhang S. Dis Markers. 2022 Mar 30;2022:3736104. doi: 10.1155/2022/3736104. eCollection 2022. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.